3 months ago
MRK
AnalystsLouise ChenLouise Chen's Stock Forecasts
AnalystsLouise Chen
Analyst Ranking
Bottom 5%
#3996 out of 4172 analysts
Average Return
-21.53%
Win Rate
26%11 out of 42
Risk vs Reward
Poor
Good
Louise Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Soliton IncSOLY | +173.71% | $8.14 | $22.28 | 2020-07-14 - 2021-05-13 | Strong Buy |
I MabIMAB | +111.17% | $29.80 | $62.93 | 2020-07-26 - 2021-07-26 | Strong Buy |
Roivant Sciences LtdROIV | +94.58% | $3.69 | $7.18 | 2022-04-28 - 2023-03-27 | Strong Buy |
Eli Lilly & CoLLY | +34.23% | $232.97 | $312.72 | 2021-06-23 - 2022-06-23 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +30.04% | $26.33 | $34.24 | 2020-02-24 - 2021-02-25 | Strong Buy |
Louise Chen Analyst Color
Get additional color on Louise Chen's coverage of popular stocks
Louise Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $5.00 | +395.05% | Reiterates | 20 days ago |
Immunovant IncIMVT | 1 | Strong Buy | $30.00 | +91.69% | Initiates Coverage On | a month ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $38.00 | +366.83% | Reiterates | 2 months ago |
Pfizer IncPFE | 1 | Strong Buy | $75.00 | +86.47% | Reiterates | 2 months ago |
Johnson & JohnsonJNJ | 2 | Strong Buy | $215.00 | +40.25% | Reiterates | 2 months ago |
Mesoblast LtdMESO | 1 | Strong Buy | $23.00 | +631.32% | Reiterates | 2 months ago |
Cutera IncCUTR | 2 | Hold | $33.00 | +26.20% | Downgrades | 3 months ago |
Therapeuticsmd IncTXMD | 3 | Hold | $5.00 | +34.59% | Reinstates | 3 months ago |
Humanigen IncHGEN | 3 | Hold | $0.15 | +11.11% | Reinstates | 3 months ago |
Merck & Co IncMRK | 1 | Strong Buy | $135.00 | +26.25% | Maintains | 3 months ago |
Contrafect CorpCFRX | 2 | Hold | $80.00 | +3,471.43% | Downgrades | 8 months ago |
Connect Biopharma Holdings LtdCNTB | 1 | Strong Buy | $5.00 | +488.24% | Initiates Coverage On | 10 months ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $20.00 | +952.63% | Initiates Coverage On | 10 months ago |
Lyra Therapeutics IncLYRA | 1 | Strong Buy | $15.00 | +621.15% | Initiates Coverage On | 10 months ago |
Spero Therapeutics IncSPRO | 1 | Strong Buy | $5.00 | +254.61% | Maintains | 10 months ago |
Ardelyx IncARDX | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Entasis Therapeutics Holdings IncETTX | 2 | Hold | $2.00 | -8.68% | Downgrades | a year ago |
Roivant Sciences LtdROIV | 1 | Strong Buy | $15.00 | +108.91% | Initiates Coverage On | a year ago |
Rvl Pharmaceuticals PLCRVLP | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Effector Therapeutics IncEFTR | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Jaguar Health IncJAGX | 1 | Strong Buy | $1,125.00 | N/A | Initiates Coverage On | 2 years ago |
Pds Biotechnology CorpPDSB | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Eli Lilly & CoLLY | 2 | Strong Buy | $300.00 | N/A | Maintains | 2 years ago |
I MabIMAB | 2 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Soliton IncSOLY | 2 | Hold | $22.60 | N/A | Downgrades | 2 years ago |
Scynexis IncSCYX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Factset Research Systems IncFDS | 1 | Hold | $258.00 | N/A | Maintains | 3 years ago |
Arcutis Biotherapeutics IncARQT | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Teva Pharmaceutical Industries LtdTEVA | 2 | Hold | $15.00 | N/A | Maintains | 3 years ago |
Aravive IncARAV | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Endo International PLCENDPQ | 2 | Hold | $18.00 | N/A | Maintains | 4 years ago |
Heron Therapeutics IncHRTX | 1 | Strong Buy | $50.00 | N/A | Maintains | 5 years ago |
Evolus IncEOLS | 1 | Strong Buy | $35.00 | N/A | Maintains | 5 years ago |
Allergan PLCAGN | 1 | Hold | $180.00 | N/A | Maintains | 5 years ago |
Impax Laboratories IncIPXL | 2 | Strong Buy | $35.00 | N/A | Maintains | 5 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 5 years ago |
Opko Health IncOPK | 2 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Neos Therapeutics IncNEOS | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 6 years ago |
Dermira IncDERM2 | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.